AI-powered IND strategy & filings, in half the time.
Panacea provides the first AI-enabled Regulatory Affairs team, with decades of regulatory expertise, to accelerate your IND approval.

25+ Years
of Experience
About us
File submissions in half the time
Our Regulatory Affairs team uses our AI platform, Elixir, to move 10x faster. This reduces strategy and authoring timelines from months, to just days.
01
Highest quality, every time
Our team has decades of regulatory experience. Our AI platform ensures a high approval rate with no gaps in your final submission.
02
Pay for outcomes, not hours
No payment upfront, no hourly billing. We price on value provided, and you only pay when we deliver on mutually agreed milestones.
03
how it works
Customer Stories
Fast-Tracking an ADC Toward IND Clearance: From Asset Purchase to FDA Dossier in 9 Months
Supporting a Debut BLA Filing for a Cell & Gene Therapy Oncology Company
Execution of U.S. ANDA Filings Through a Domestic CRO Partner
Team Spotlight
Harun Sinha

CMC Regulatory Strategist
25+ Years Experience
Is Panacea just another FDA regulatory consulting firm?
What does working with your team look like?
How does pricing work?
When should we engage with you?
What kind of companies do you work with?

Accelerate your IND approval today.
Get in touch today to discuss your needs, timelines, and how we can work together to fast-track your FDA approval!